The Impact of Body Mass Index on Inpatient- Versus Outpatient-treated Chronic Obstructive Pulmonary Disease Exacerbations

Overview

Journal Can Respir J

Publisher Wiley

Specialty Pulmonary Medicine

Date 2013 May 30

PMID 23717822

Citations 2

Authors

Ariane Jacob

Catherine Laurin

Kim L Lavoie

Gregory Moullec

Maxine Boudreau

Catherine Lemiere

Simon Bacon

Affiliations

Soon will be listed here.

Abstract

Background: Increased body weight has been associated with worse prognoses for many chronic diseases; however, this relationship is less clear in patients with chronic obstructive pulmonary disease (COPD), with underweight patients experiencing higher morbidity than normal or overweight patients.

Objective: To assess the impact of body mass index (BMI) on the risk for COPD exacerbations.

Methods: The present study included 115 patients with stable COPD (53% women; mean [± SD] age 67±8 years). Height and weight were measured to calculate BMI. Patients were followed for a mean of 1.8±0.8 years to assess the prospective risk of inpatient-treated exacerbations and outpatient-treated exacerbations, all of which were verified by chart review.

Results: Cox regression models revealed that underweight patients were at greater risk for inhospital-treated exacerbations (RR 2.93 [95% CI 1.27 to 6.76) relative to normal weight patients. However, overweight (RR 0.59 [95% CI 0.33 to 1.57) and obese (RR 0.99 [95% CI 0.53 to 1.86]) patients did not differ from normal weight patients. All analyses were adjusted for age, sex, length of diagnosis, smoking pack-years, forced expiratory volume in 1 s, and time between recruitment and last exacerbation. BMI did not influence the risk of out-of-hospital exacerbations.

Conclulsions: The present study showed that underweight patients were at greater risk for inhospital exacerbations. However, BMI did not appear to be a risk factor for out-of-hospital exacerbations. This suggests that the BMI-exacerbation link may differ according to the nature of the exacerbation, the mechanisms for which are not yet known.

Citing Articles

Impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan Obstructive Lung Disease cohort.

Wei Y, Tsai Y, Wang C, Kuo P Int J Chron Obstruct Pulmon Dis. 2017; 12:2723-2729.

PMID: 28979114 PMC: 5602448. DOI: 10.2147/COPD.S138571.

Prediction models for exacerbations in patients with COPD.

Guerra B, Gaveikaite V, Bianchi C, Puhan M Eur Respir Rev. 2017; 26(143).

PMID: 28096287 PMC: 9489020. DOI: 10.1183/16000617.0061-2016.

References

Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-38. DOI: 10.1056/NEJMoa0909883. View

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

Calverley P . COPD: early detection and intervention. Chest. 2000; 117(5 Suppl 2):365S-71S. DOI: 10.1378/chest.117.5_suppl_2.365s. View

Worth H . Self management in COPD: one step beyond?. Patient Educ Couns. 1998; 32(1 Suppl):S105-9. DOI: 10.1016/s0738-3991(97)00102-x. View

Engelen M, Schols A, Baken W, Wesseling G, Wouters E . Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J. 1994; 7(10):1793-7. DOI: 10.1183/09031936.94.07101793. View

Wouters E . Nutrition and metabolism in COPD. Chest. 2000; 117(5 Suppl 1):274S-80S. DOI: 10.1378/chest.117.5_suppl_1.274s. View

Kochanek K, Xu J, Murphy S, Minino A, Kung H . Deaths: preliminary data for 2009. Natl Vital Stat Rep. 2014; 59(4):1-51. View

Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R . Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003; 163(5):585-91. DOI: 10.1001/archinte.163.5.585. View

Chen Y, Narsavage G . Factors related to chronic obstructive pulmonary disease readmission in Taiwan. West J Nurs Res. 2006; 28(1):105-24. DOI: 10.1177/0193945905282354. View

10.

Seemungal T, Donaldson G, Paul E, Bestall J, Jeffries D, Wedzicha J . Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5 Pt 1):1418-22. DOI: 10.1164/ajrccm.157.5.9709032. View

11.

Sahebjami H, Sathianpitayakul E . Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161(3 Pt 1):886-90. DOI: 10.1164/ajrccm.161.3.9905023. View

12.

Gold P . The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care. 2009; 54(8):1040-9. View

13.

Gray-Donald K, Gibbons L, SHAPIRO S, Macklem P, Martin J . Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996; 153(3):961-6. DOI: 10.1164/ajrccm.153.3.8630580. View

14.

Ramsey S, Hobbs F . Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. Proc Am Thorac Soc. 2006; 3(7):635-40. DOI: 10.1513/pats.200603-094SS. View

15.

Schembri S, Anderson W, Morant S, Winter J, Thompson P, Pettitt D . A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med. 2009; 103(10):1461-7. DOI: 10.1016/j.rmed.2009.04.021. View

16.

Burge S, Wedzicha J . COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003; 41:46s-53s. DOI: 10.1183/09031936.03.00078002. View

17.

Oostenbrink J, Molken M . Resource use and risk factors in high-cost exacerbations of COPD. Respir Med. 2004; 98(9):883-91. DOI: 10.1016/j.rmed.2004.02.013. View

18.

Donahoe M, Rogers R, WILSON D, Pennock B . Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989; 140(2):385-91. DOI: 10.1164/ajrccm/140.2.385. View

19.

Xu W, Collet J, Shapiro S, Lin Y, Yang T, Wang C . Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J. 2009; 35(5):1022-30. DOI: 10.1183/09031936.00079409. View

20.

Andersson F, Borg S, Jansson S, Jonsson A, Ericsson A, Prutz C . The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med. 2002; 96(9):700-8. DOI: 10.1053/rmed.2002.1334. View